Pavion Blue Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-508
Closed -$266K 105
2025
Q1
$266K Hold
508
0.13% 83
2024
Q4
$257K Hold
508
0.12% 85
2024
Q3
$297K Sell
508
-10
-2% -$5.66K 0.14% 79
2024
Q2
$264K Hold
518
0.13% 84
2024
Q1
$256K Sell
518
-6
-1% -$3.05K 0.13% 83
2023
Q4
$276K Hold
524
0.15% 79
2023
Q3
$264K Hold
524
0.16% 79
2023
Q2
$252K Sell
524
-145
-22% -$70.9K 0.15% 84
2023
Q1
$316K Hold
669
0.19% 73
2022
Q4
$355K Buy
669
+145
+28% +$76.8K 0.23% 68
2022
Q3
$265K Hold
524
0.19% 73
2022
Q2
$269K Buy
524
+17
+3% +$8.54K 0.18% 73
2022
Q1
$259K Hold
507
0.15% 79
2021
Q4
$255K Buy
+507
New +$230K 0.15% 81
2021
Q3
Sell
-507
Closed -$203K 93
2021
Q2
$203K Sell
507
-175
-26% -$69.8K 0.12% 92
2021
Q1
$254K Hold
682
0.17% 74
2020
Q4
$239K Sell
682
-268
-28% -$89.8K 0.16% 79
2020
Q3
$296K Buy
950
+90
+10% +$27.6K 0.23% 64
2020
Q2
$254K Hold
860
0.22% 68
2020
Q1
$214K Hold
860
0.22% 67
2019
Q4
$253K Buy
+860
New +$225K 0.25% 53

Other funds holding UNH

Pavion Blue Capital's UNH Position: Q2 2025 in Review

Pavion Blue Capital sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 508 shares — an estimated $266K sold.

Pavion Blue Capital first reported a position in UNH in Q4 2019 and held it in 21 quarters. The position peaked at $355K in Q4 2022. 3,178 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Pavion Blue Capital reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Pavion Blue Capital sold 508 UnitedHealth shares in Q2 2025, an estimated $266K.
  • Pavion Blue Capital first reported a position in UnitedHealth in Q4 2019 and held it in 21 quarters.
  • Pavion Blue Capital's UnitedHealth position peaked at $355K in Q4 2022.
  • 3,178 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Pavion Blue Capital's 13F filing for Q2 2025, filed 1 Aug 2025.